Oral and gut microbiome profiles in people with early idiopathic Parkinson's disease/Experiment 8

From BugSigDB


Needs review

Curated date: 2024/11/07

Curator: KateRasheed

Revision editor(s): KateRasheed

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Parkinson disease, mitochondrial Parkinson disease, mitochondrial,parkinson disease, mitochondrial
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Parkinson’s disease patients (PD patients)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Parkinson’s disease patients (PD patients) refer to patients with Parkinson's disease - a neurodegenerative disease that is characterized by both motor symptoms, such as tremors, and non-motor symptoms, such as constipation.
Group 0 sample size Number of subjects in the control (unexposed) group
221
Group 1 sample size Number of subjects in the case (exposed) group
445
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, sex
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, body mass index, smoking status, Confounders controlled for: "dessert consumption frequency" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.dessert consumption frequency, Confounders controlled for: "flossing teeth frequency" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.flossing teeth frequency, Confounders controlled for: "laxative use in the past month" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.laxative use in the past month, Confounders controlled for: "number of weekly bowel movements" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.number of weekly bowel movements, Confounders controlled for: "US census region" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.US census region

Alpha Diversity

Chao1 Abundance-based estimator of species richness
increased

Signature 1

Needs review

Curated date: 2024/11/07

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Data 2

Description: Significant differentially abundant OTU-level microbial taxa (gut microbiota) between controls and PD cases (after adjustment for covariates) using linear models statistical test.

Abundance in Group 1: increased abundance in Parkinson’s disease patients (PD patients)

NCBI Quality ControlLinks
Streptococcus sp. HMSC072D03
Streptococcus_vestibularis_22.06_S6Streptococcus_vestibularis_22.06_S6
Anaerostipes_hadrus_2789STDY5834908Anaerostipes_hadrus_2789STDY5834908
Blautia_obeum_2789STDY5608837Blautia_obeum_2789STDY5608837
Streptococcus_salivarius_HSISS4Streptococcus_salivarius_HSISS4
Ruminococcaceae bacterium D16
Bifidobacterium dentium ATCC 27679
Burkholderiales bacterium 1_1_47

Revision editor(s): KateRasheed

Signature 2

Needs review

Curated date: 2024/11/07

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Data 2

Description: Significant differentially abundant OTU-level microbial taxa (gut microbiota) between controls and PD cases (after adjustment for covariates) using linear models statistical test.

Abundance in Group 1: decreased abundance in Parkinson’s disease patients (PD patients)

NCBI Quality ControlLinks
Clostridium sp. SN20
X.Ruminococcus._gnavus_RJX1119X.Ruminococcus._gnavus_RJX1119
Faecalibacterium_prausnitzii_IndicaFaecalibacterium_prausnitzii_Indica
Faecalibacterium_prausnitzii_CNCM_I_4574Faecalibacterium_prausnitzii_CNCM_I_4574
Bacteroides sp. HMSC067B03
Bacteroides_cellulosilyticus_CL09T06C25Bacteroides_cellulosilyticus_CL09T06C25
Bacteroides_uniformis_2789STDY5834847Bacteroides_uniformis_2789STDY5834847
Fusicatenibacter_saccharivorans_2789STDY5834923Fusicatenibacter_saccharivorans_2789STDY5834923
Bacteroides cellulosilyticus WH2
Clostridium_phoceensis_GD3Clostridium_phoceensis_GD3
Bacteroides sp. 3_1_13
Parabacteroides gordonii MS-1 = DSM 23371
Phocaeicola sartorii dnLKV3
Parabacteroides distasonis CL03T12C09
Bacteroides cellulosilyticus CL02T12C19
Parabacteroides sp. 20_3
Faecalibacterium_prausnitzii_A2.165Faecalibacterium_prausnitzii_A2.165
Roseburia intestinalis L1-82
Faecalibacterium_prausnitzii_M21.2Faecalibacterium_prausnitzii_M21.2

Revision editor(s): KateRasheed